Net Income Summary of Novartis AG

Novartis AG's latest annual net income in 2023 was 14.85 Billion USD , up 113.52% from previous year.
Novartis AG's latest quarterly net income in 2024 Q3 was 3.18 Billion USD , down -1.76% from previous quarter.
Novartis AG reported an annual net income of 6.95 Billion USD in 2022, down -71.05% from previous year.
Novartis AG reported an annual net income of 24.02 Billion USD in 2021, up 197.58% from previous year.
Novartis AG reported a quarterly net income of 2.68 Billion USD for 2024 Q1, down -68.3% from previous quarter.
Novartis AG reported a quarterly net income of 3.24 Billion USD for 2024 Q2, up 20.76% from previous quarter.

Annual Net Income Chart of Novartis AG (2023 - 1998)

Historical Annual Net Income of Novartis AG (2023 - 1998)

Year	Net Income	Net Income Growth
2023	14.85 Billion USD	113.52%
2022	6.95 Billion USD	-71.05%
2021	24.02 Billion USD	197.58%
2020	8.07 Billion USD	12.94%
2019	7.14 Billion USD	-43.33%
2018	12.61 Billion USD	63.72%
2017	7.7 Billion USD	14.76%
2016	6.71 Billion USD	-62.26%
2015	17.78 Billion USD	74.17%
2014	10.21 Billion USD	11.28%
2013	9.17 Billion USD	-3.47%
2012	9.5 Billion USD	4.3%
2011	9.11 Billion USD	-6.95%
2010	9.79 Billion USD	16.6%
2009	8.4 Billion USD	2.5%
2008	8.19 Billion USD	-31.4%
2007	11.94 Billion USD	66.49%
2006	7.17 Billion USD	17.05%
2005	6.13 Billion USD	6.29%
2004	5.76 Billion USD	14.97%
2003	5.01 Billion USD	-3.98%
2002	5.22 Billion USD	23.24%
2001	4.23 Billion USD	-3.55%
2000	4.39 Billion USD	4.94%
1999	4.18 Billion USD	-4.97%
1998	4.4 Billion USD	0.0%

Year	Net Income	Net Income Growth
2024 Q3	3.18 Billion USD	-1.76%
2024 Q1	2.68 Billion USD	-68.3%
2024 Q2	3.24 Billion USD	20.76%
2023 Q4	8.48 Billion USD	381.54%
2023 FY	14.85 Billion USD	113.52%
2023 Q1	2.29 Billion USD	56.41%
2023 Q2	2.31 Billion USD	1.0%
2023 Q3	1.76 Billion USD	-23.96%
2022 Q2	1.69 Billion USD	-23.76%
2022 Q3	1.57 Billion USD	-7.14%
2022 Q4	1.46 Billion USD	-6.8%
2022 FY	6.95 Billion USD	-71.05%
2022 Q1	2.22 Billion USD	-86.37%
2021 Q2	2.89 Billion USD	40.65%
2021 Q4	16.3 Billion USD	491.3%
2021 FY	24.02 Billion USD	197.58%
2021 Q1	2.05 Billion USD	-1.67%
2021 Q3	2.75 Billion USD	-4.77%
2020 Q3	1.93 Billion USD	3.64%
2020 FY	8.07 Billion USD	12.94%
2020 Q1	2.17 Billion USD	93.42%
2020 Q4	2.09 Billion USD	8.22%
2020 Q2	1.86 Billion USD	-14.2%
2019 Q4	1.12 Billion USD	-44.91%
2019 Q1	1.76 Billion USD	47.78%
2019 Q3	2.04 Billion USD	-69.97%
2019 FY	7.14 Billion USD	-43.33%
2019 Q2	6.79 Billion USD	284.99%
2018 Q1	2.02 Billion USD	2.48%
2018 Q4	1.19 Billion USD	-26.37%
2018 FY	12.61 Billion USD	63.72%
2018 Q3	1.62 Billion USD	-79.11%
2018 Q2	7.76 Billion USD	283.6%
2017 Q3	2.08 Billion USD	5.1%
2017 FY	7.7 Billion USD	14.76%
2017 Q4	1.97 Billion USD	-5.05%
2017 Q2	1.98 Billion USD	18.85%
2017 Q1	1.66 Billion USD	74.09%
2016 FY	6.71 Billion USD	-62.26%
2016 Q4	957 Million USD	-50.67%
2016 Q3	1.94 Billion USD	7.54%
2016 Q2	1.8 Billion USD	-10.29%
2016 Q1	2.01 Billion USD	90.8%
2015 Q2	1.83 Billion USD	-85.88%
2015 Q1	13 Billion USD	772.23%
2015 FY	17.78 Billion USD	74.17%
2015 Q3	1.88 Billion USD	2.83%
2015 Q4	1.05 Billion USD	-44.17%
2014 Q4	1.49 Billion USD	-53.74%
2014 FY	10.21 Billion USD	11.28%
2014 Q3	3.22 Billion USD	26.14%
2014 Q2	2.55 Billion USD	-13.12%
2014 Q1	2.94 Billion USD	44.95%
2013 Q4	2.02 Billion USD	-9.09%
2013 Q3	2.23 Billion USD	-11.29%
2013 FY	9.17 Billion USD	-3.47%
2013 Q2	2.51 Billion USD	4.92%
2013 Q1	2.39 Billion USD	17.26%
2012 Q3	2.44 Billion USD	-9.5%
2012 Q4	2.04 Billion USD	-16.5%
2012 FY	9.5 Billion USD	4.3%
2012 Q1	2.3 Billion USD	96.17%
2012 Q2	2.7 Billion USD	17.4%
2011 Q4	1.17 Billion USD	-52.31%
2011 FY	9.11 Billion USD	-6.95%
2011 Q2	2.7 Billion USD	-2.38%
2011 Q3	2.46 Billion USD	-8.88%
2011 Q1	2.77 Billion USD	27.71%
2010 Q3	2.27 Billion USD	-5.88%
2010 FY	9.79 Billion USD	16.6%
2010 Q1	2.93 Billion USD	27.25%
2010 Q2	2.41 Billion USD	-17.59%
2010 Q4	2.16 Billion USD	-4.66%
2009 Q3	2.09 Billion USD	3.1%
2009 Q1	1.96 Billion USD	27.49%
2009 Q2	2.03 Billion USD	3.72%
2009 Q4	2.3 Billion USD	9.87%
2009 FY	8.4 Billion USD	2.5%
2008 Q3	2.09 Billion USD	-7.07%
2008 Q4	1.53 Billion USD	-26.36%
2008 FY	8.19 Billion USD	-31.4%
2008 Q2	2.24 Billion USD	-2.93%
2008 Q1	2.31 Billion USD	156.31%
2007 Q4	904 Million USD	-86.83%
2007 Q2	2 Billion USD	-7.42%
2007 Q1	2.16 Billion USD	31.14%
2007 FY	11.94 Billion USD	66.49%
2007 Q3	6.86 Billion USD	241.88%
2006 Q3	1.86 Billion USD	9.37%
2006 FY	7.17 Billion USD	17.05%
2006 Q2	1.7 Billion USD	-12.33%
2006 Q4	1.65 Billion USD	-11.41%
2006 Q1	1.94 Billion USD	44.22%
2005 FY	6.13 Billion USD	6.29%
2005 Q1	1.48 Billion USD	7.47%
2005 Q2	1.64 Billion USD	11.14%
2005 Q3	1.65 Billion USD	0.79%
2005 Q4	1.35 Billion USD	-18.63%
2004 Q2	1.54 Billion USD	19.8%
2004 Q1	1.29 Billion USD	-4.93%
2004 Q3	1.54 Billion USD	-0.13%
2004 Q4	1.37 Billion USD	-10.92%
2004 FY	5.76 Billion USD	14.97%
2003 Q1	1.06 Billion USD	-36.65%
2003 Q3	1.27 Billion USD	-2.96%
2003 FY	5.01 Billion USD	-3.98%
2003 Q4	1.36 Billion USD	6.5%
2003 Q2	1.31 Billion USD	23.8%
2002 Q2	1.39 Billion USD	27.71%
2002 Q1	1.09 Billion USD	5.62%
2002 FY	5.22 Billion USD	23.24%
2002 Q4	1.67 Billion USD	51.04%
2002 Q3	1.11 Billion USD	-20.19%
2001 Q1	1.07 Billion USD	-1.92%
2001 FY	4.23 Billion USD	-3.55%
2001 Q3	1.12 Billion USD	8.57%
2001 Q4	1.03 Billion USD	-8.51%
2001 Q2	1.03 Billion USD	-2.99%
2000 FY	4.39 Billion USD	4.94%
2000 Q4	1.09 Billion USD	24.66%
2000 Q1	1.25 Billion USD	0.0%
2000 Q2	1.28 Billion USD	1.91%
2000 Q3	876 Million USD	-31.67%
1999 FY	4.18 Billion USD	-4.97%
1998 FY	4.4 Billion USD	0.0%

Peer Net Income Comparison of Novartis AG

Name	Net Income	Net Income Difference
AbbVie Inc.	4.86 Billion USD	-205.367%
Bristol-Myers Squibb Company	8.02 Billion USD	-85.047%
Bristol-Myers Squibb Company Ce	8.02 Billion USD	-85.047%
Johnson & Johnson	35.15 Billion USD	57.756%
Eli Lilly and Company	5.24 Billion USD	-183.375%
Merck & Co., Inc.	365 Million USD	-3968.493%
Organon & Co.	1.02 Billion USD	-1351.613%
Pfizer Inc.	2.11 Billion USD	-600.802%

Global Stocks Search

Novartis AG (NVS)

Net Income Summary of Novartis AG

Annual Net Income Chart of Novartis AG (2023 - 1998)

Historical Annual Net Income of Novartis AG (2023 - 1998)

Peer Net Income Comparison of Novartis AG